Complegen Inc is categorized under Commercial Biotechnical Research in Seattle, WA and active since 2000.
Complegen Inc was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact John Swindle, Chief Executive Officer at the company’s single location by writing to 1124 Columbia St # 662, Seattle, Washington WA 98104 or by phoning (206) 447-8076. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Complegen Inc |
| Contact Person: | John Swindle, Chief Executive Officer |
| Address: | 1124 Columbia St # 662, Seattle, Washington 98104 |
| Phone Number: | (206) 447-8076 |
| Website Address: | complegen.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Complegen Inc was started in 2000 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact John Swindle, Chief Executive Officer for inquiries that concern Complegen Inc by calling the company number (206) 447-8076, as your correspondence is most welcome. Additionally, the physical location of the single location of Complegen Inc can be found at the coordinates 47.60818,-122.32332 as well as the street address 1124 Columbia St # 662 in Seattle, Washington 98104.
For its online presence, you may visit Complegen Inc’s website at complegen.com and engage with its social media outlets through on Twitter and on Facebook.